Loading page…
Search companies, filings, portfolio…
⌘K
Sign in
Sign up
BP
Bafna Pharmaceuticals Limited
NSE:
BAFNAPH
BSE:
BAFNAPH
Healthcare
Pharmaceuticals & Biotechnology
₹378.8
+1.99%
1 Oct close
Mkt cap
₹898 Cr
Watch
Alert
Compare
Overview
Chart
Peers
Profit & loss
Balance sheet
Cash flow
Ratios
Shareholding
F&O
Documents
Events
Announcements
Notes
Annual
Quarterly
Consolidated
Standalone
Consolidated figures · ₹ crore
Quarterly results
₹ Cr
Mar 2020
Revenue
13
COGS
5
Gross profit
8
Operating expenses
+
4
Operating profit (EBITDA)
+
4
OPM %
30.1%
Depreciation
1
Interest
0
Other income
+
-2
Profit before tax
2
Tax
2
Tax %
83.6%
PAT
0
PAT margin %
2.4%
EPS (₹)
0.2